Rhythm Pharmaceuticals Inc
RYTM Earnings — EPS History, Revenue & Growth
Reported earnings per share, revenue and net income for RYTM across recent quarters, with growth rates, margins and how those earnings translate into the multiple the market is paying today.
RYTM Earnings Per Share (TTM)
- Revenue (TTM)
- $217.16M
- Net income (TTM)
- $-202.68M
- EPS growth
- —
- Revenue growth
- +46.9%
- Net margin
- -85.6%
- P/E on these earnings
- —
RYTM Quarterly EPS History
Reported earnings per share for RYTM by quarter. Consistency matters as much as size — a smooth rising series earns a higher multiple than a volatile one.
RYTM Revenue by Quarter
Top-line revenue for RYTM. Earnings growth that outpaces revenue growth comes from margin expansion, which is finite; revenue growth is the durable driver.
RYTM Earnings Results by Period
The last 12 reported periods for RYTM, most recent first.
| Period | EPS | Revenue | Net income | Net margin |
|---|---|---|---|---|
| Q1 2026 | $0.00 | $60.11M | $-55.64M | -92.6% |
| Q4 2025 | $-1.00 | $57.25M | $-47.51M | -83.0% |
| Q3 2025 | $-1.00 | $51.30M | $-52.90M | -103.1% |
| Q2 2025 | $-1.00 | $48.50M | $-46.63M | -96.1% |
| Q1 2025 | $0.00 | $32.70M | $-49.50M | -151.4% |
| Q4 2024 | $-1.00 | $41.83M | $-43.29M | -103.5% |
| Q3 2024 | $-1.00 | $88.30M | $-43.68M | -49.5% |
| Q2 2024 | $0.00 | — | $-32.26M | — |
| Q1 2024 | $-2.00 | — | $-141.37M | — |
| Q4 2023 | $-1.00 | — | $-41.63M | — |
| Q3 2023 | $-1.00 | — | $-44.16M | — |
| Q2 2023 | $-1.00 | — | $-46.70M | — |
Earnings vs Valuation & Market Positioning
Earnings set the base; the multiple and the statistical stretch of the price decide what you actually pay.
- Market cap
- $6.73B
- Trailing P/E
- —
- Forward P/E
- —
- Gross margin
- +70.9%
How This RYTM Earnings Data Is Built
Quarterly EPS, revenue and net income are pulled from RYTM's reported filings through live ZCoreAI market endpoints. Trailing twelve-month figures sum the last four reported quarters. Net margin per period is net income divided by revenue for that same period, and year-over-year comparisons use the quarter four periods back to avoid seasonality distortions.
Growth rates come from the same reported series rather than adjusted or non-GAAP management figures, so they can differ from headline numbers quoted in company presentations. Nothing on this page is investment advice.
RYTM Earnings FAQ
What are RYTM earnings per share?
RYTM reported trailing twelve-month EPS of $-3.05, the sum of the last four reported quarters divided across shares outstanding.
Are RYTM earnings growing?
A growth rate for RYTM is not available from the latest reported figures.
When does RYTM report earnings?
RYTM reports on a quarterly cycle. The table above shows the most recent reported periods; the next release typically follows roughly three months after the latest period shown.
How do RYTM earnings affect the stock price?
Price equals earnings times the multiple. every dollar of EPS added or lost is amplified by that multiple, which is why earnings surprises move the price far more than the size of the surprise alone.
Where does ZCoreAI get RYTM earnings data?
Reported EPS, revenue, net income and margins come from live ZCoreAI market endpoints sourced from company filings, refreshed on every page load.
Income statement, margins, cash and debt for RYTM.
Trailing and forward multiples, PEG and earnings yield for RYTM.
DCF fair value, price prediction and signal targets for RYTM.
Live chart, fundamentals and valuation context for RYTM.
Payout history, yield and dividend growth for RYTM.
Data refreshed from live ZCoreAI market endpoints. Informational only — not investment advice.